BioRem Overview
Valuation check: BIRMF's ROE is 35.35%, above the sector sector average of 11.75%.
Get informed when a big investor buys or sells
+ Follow35.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for BIRMF is 35.35%. That is above the sector sector average of 11.75%. Investors often review this figure alongside BioRem's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, BIRMF currently prints 35.35% for ROE, while the sector average sits near 11.75%. That is roughly 200.8% above the sector mean. Large gaps often invite a closer look at BioRem's growth, margins, and balance sheet.
Return on Equity shows how effectively BioRem converts resources into returns. At 35.35%, BIRMF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BIRMF's ROE (35.35%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
